(Bloomberg) -- Medtronic Inc. is looking beyond medical devices, seeking to expand within hospitals and connect directly with patients as it moves into a health-services industry projected to grow as Obamacare expands coverage.
The world’s biggest maker of devices to regulate the heart’s rhythm signaled its move last week with its $200 million acquisition of Cardiocom, which provides monitoring services to patients with chronic diseases. It is pursuing contracts with about a dozen large European medical centers to run their cardiac catheterization laboratories, where hearts are examined and stents are implanted to prop open arteries.
Register or login for access to this item and much more
All Employee Benefit News content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access